Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Covid-19

Think about booster vaccination now!

    • General Internal Medicine
    • Infectiology
    • News
    • Prevention and health care
    • RX
  • 2 minute read

As of 10/10/2022, another Covid-19 booster vaccine is available. The FOPH and the Federal Vaccination Commission (EKIF) recommend booster vaccination primarily to those at particular risk and to health professionals. The cantons are responsible for the implementation. The costs for the booster vaccination are covered by the federal government.

(red) Currently, both the number of reported cases with SARS-CoV-2 infections and the proportion of positive tests are increasing significantly. This trend is also observed in national wastewater monitoring, where the measured viral load in wastewater is increasing. Fortunately, the proportion of ICU beds occupied by Covid 19 patients and reported deaths remain at very low levels. However, the incidence of infection is expected to continue to increase.

On Monday, October 10, 2022, the adjusted Covid 19 vaccine recommendations went into effect. Another booster vaccination can help reduce the number of severe illnesses and thus overload the health care system in the fall and winter. The vaccination recommendation is aimed primarily at persons at particular risk, i.e. persons over 65 years of age and those with an increased individual health risk, for example due to a specific previous illness or pregnancy. These groups have the highest risk of developing severe covid-19. With a booster vaccination, they improve their individual protection against a severe course of the disease, at least temporarily. The recommendation applies secondarily to persons between the ages of 16 and 64 years without risk factors who are involved in acute and long-term care or who provide professional or personal care to persons who are particularly at risk. Booster vaccination offers these individuals some protection against infection with disease and may also reduce work absenteeism to some degree.

A general recommendation also exists for all other individuals aged 16 to 64 years with no risk factors. For them, a booster vaccination makes sense after individual consideration and decision if they want to reduce the risk of infection or a rare severe course. However, individuals without risk factors are at low risk for severe disease in the fall of 2022, unlike at the beginning of the pandemic. Children and adolescents between the ages of 5 and 15 years are not recommended to receive a booster vaccination in the fall of 2022 in the current situation because their risk of severe Covid 19 disease is very low. All vaccinations recommended by BAG and EKIF are free of charge for the vaccinated.

Source: www.bag.admin.ch/bag/de/home/das-bag/aktuell/medienmitteilungen.msg-id-90601.html (last accessed on 22.10.2022)

 

InFo ONCOLOGY & HEMATOLOGY 2022; 10(5): 37.

Publikation
  • InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
  • booster
  • CORONA
  • covid
  • Vaccination
Previous Article
  • Immune system becomes a data logger

Bacteria with uptake function capture intestinal health

  • Gastroenterology and Hepatology
  • General Internal Medicine
  • RX
  • Studies
View Post
Next Article
  • Radiation protection

Annual report of the Radiation Protection Division published

  • Cardiology
  • Education
  • General Internal Medicine
  • Nuclear Medicine
  • Oncology
  • Prevention and health care
  • Radiology
  • RX
View Post
You May Also Like
View Post
  • 7 min
  • Plastic surgery and reconstructive microsurgery for DFS

Functional limb preservation between infection control, vascular medicine and resurfacing

    • RX
    • Angiology
    • CME continuing education
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Geriatrics
    • Physical medicine and rehabilitation
    • Surgery
View Post
  • 12 min
  • SURPASS-CVOT

Tirzepatide versus Dulaglutide in T2D with ASCVD

    • RX
    • Cardiology
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Pharmacology and toxicology
    • Studies
View Post
  • 6 min
  • Secondary prevention after ACS: individually optimized lipid management

Trend towards early combination therapy and new strategies for lowering Lp(a)

    • RX
    • Cardiology
    • Congress Reports
    • General Internal Medicine
    • Studies
View Post
  • 27 min
  • Pediatric Brain Tumors

Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls

    • RX
    • CME continuing education
    • Neurology
    • Oncology
    • Pediatrics
    • Psychiatry and psychotherapy
    • Studies
View Post
  • 13 min
  • What the latest studies on the entire EF spectrum mean for clinical practice

Heart Failure – The 2026 Evidence Update

    • RX
    • Cardiology
    • Education
    • Endocrinology and Diabetology
    • Studies
View Post
  • 5 min
  • Acute ischemic stroke

Alteplase and Tenecteplase Are on the Same Level

    • RX
    • Education
    • Emergency and intensive care medicine
    • Neurology
    • Pharmacology and toxicology
    • Studies
View Post
  • 5 min
  • CKD in People with Type 2 Diabetes: Evidence-Based, Optimized Treatment

SGLT-2 inhibitors and GLP-1 receptor agonists: significant improvement in renal outcomes

    • RX
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nephrology
    • Studies
View Post
  • 2 min
  • Wearables: screening via smartwatch?

New study on atrial fibrillation in high-risk patients

    • RX
    • Cardiology
    • Practice Management
    • Prevention and health care
    • Studies
Landingpage Fachinfo Landingpage Button
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Update on Anti-Rheumatic Medications
  • 2
    Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
  • 3
    Focus on preventive care options
  • 4
    Inflammation as a Treatment Goal in Its Own Right
  • 5
    Personalized Treatment Before a Planned Pregnancy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.